Thompson Siegel & Walmsley’s Avanos Medical AVNS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Sell |
-40
| Closed | -$1K | – | 368 |
|
2023
Q4 | $1K | Hold |
40
| – | – | ﹤0.01% | 512 |
|
2023
Q3 | $1K | Hold |
40
| – | – | ﹤0.01% | 527 |
|
2023
Q2 | $1K | Hold |
40
| – | – | ﹤0.01% | 523 |
|
2023
Q1 | $1K | Hold |
40
| – | – | ﹤0.01% | 529 |
|
2022
Q4 | $1K | Hold |
40
| – | – | ﹤0.01% | 533 |
|
2022
Q3 | $1K | Hold |
40
| – | – | ﹤0.01% | 534 |
|
2022
Q2 | $1K | Sell |
40
-15
| -27% | -$375 | ﹤0.01% | 537 |
|
2022
Q1 | $2K | Hold |
55
| – | – | ﹤0.01% | 593 |
|
2021
Q4 | $2K | Hold |
55
| – | – | ﹤0.01% | 602 |
|
2021
Q3 | $2K | Hold |
55
| – | – | ﹤0.01% | 672 |
|
2021
Q2 | $2K | Hold |
55
| – | – | ﹤0.01% | 695 |
|
2021
Q1 | $2K | Hold |
55
| – | – | ﹤0.01% | 665 |
|
2020
Q4 | $3K | Sell |
55
-20
| -27% | -$1.09K | ﹤0.01% | 644 |
|
2020
Q3 | $2K | Hold |
75
| – | – | ﹤0.01% | 630 |
|
2020
Q2 | $2K | Hold |
75
| – | – | ﹤0.01% | 633 |
|
2020
Q1 | $2K | Hold |
75
| – | – | ﹤0.01% | 620 |
|
2019
Q4 | $3K | Hold |
75
| – | – | ﹤0.01% | 686 |
|
2019
Q3 | $3K | Hold |
75
| – | – | ﹤0.01% | 698 |
|
2019
Q2 | $3K | Buy |
+75
| New | +$3K | ﹤0.01% | 708 |
|
2017
Q4 | – | Sell |
-57
| Closed | -$3K | – | 829 |
|
2017
Q3 | $3K | Sell |
57
-70
| -55% | -$3.68K | ﹤0.01% | 800 |
|
2017
Q2 | $5K | Hold |
127
| – | – | ﹤0.01% | 754 |
|
2017
Q1 | $5K | Hold |
127
| – | – | ﹤0.01% | 748 |
|
2016
Q4 | $5K | Hold |
127
| – | – | ﹤0.01% | 687 |
|
2016
Q3 | $4K | Sell |
127
-45
| -26% | -$1.42K | ﹤0.01% | 683 |
|
2016
Q2 | $6K | Hold |
172
| – | – | ﹤0.01% | 664 |
|
2016
Q1 | $5K | Sell |
172
-450
| -72% | -$13.1K | ﹤0.01% | 642 |
|
2015
Q4 | $21K | Hold |
622
| – | – | ﹤0.01% | 534 |
|
2015
Q3 | $18K | Hold |
622
| – | – | ﹤0.01% | 554 |
|
2015
Q2 | $25K | Sell |
622
-281
| -31% | -$11.3K | ﹤0.01% | 531 |
|
2015
Q1 | $44K | Sell |
903
-68
| -7% | -$3.31K | ﹤0.01% | 492 |
|
2014
Q4 | $44K | Buy |
+971
| New | +$44K | ﹤0.01% | 481 |
|